TCL Archive Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks July 25, 2014
TCL Archive NCAB Task Force Urges New Study Section For Clinical Cancer Research, Sees “Crisis” May 7, 1993